News
New research reveals how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.
Scientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science ...
2d
News-Medical.Net on MSNScientists unlock secrets of how cells navigate the bodyScientists from St. Jude Children's Research Hospital and the Medical College of Wisconsin have created a data science framework to better understand how cells travel through the body.
GPCRs are important because a significant portion of existing drugs target them to act on cells. In fact, 34% of FDA-approved drugs are based on these receptors. "Having detailed information about ...
GPCRs are important because a significant portion of existing drugs target them to act on cells. In fact, 34% of FDA-approved drugs are based on these receptors. "Having detailed information about ...
Peter Hildebrand, professor of membrane and cell biophysics at Leipzig University, who led the international study, says, ...
The stock market ended the first trading day of the week in the negative territory, with all major indices recording hefty ...
The Independent on MSN21d
Bacteria in the gut could make certain medicine less effective, researchers sayThe common gut bacteria, which work to aid digestion, have the ability to chemically process and break down the compounds of certain medications that target proteins located on the thin wall that ...
Exicure’s subsidiary, GPCR Therapeutics doses 19th patient in its phase 2 study of GPC-100 in multiple myeloma: Redwood City, California Wednesday, April 16, 2025, 18:00 Hrs [IS ...
Exicure, Inc. (Nasdaq: XCUR) today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 (burixafor), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results